VBK.DE stock jumped 8.70% to €25.48 intraday on 11 Feb 2026 as traders positioned ahead of VERBIO’s scheduled earnings on 12 Feb 2026. Volume of 322,544 shares traded versus a 30‑day average of 131,355, signalling heavier interest. The move follows a strong six‑month rally and leaves the stock above its 50‑day average of €21.96 and 200‑day average of €14.54. Investors will focus on margins, biomethane volumes, and guidance. We track valuation, technicals, and a model forecast from Meyka AI ahead of the report.
VBK.DE stock: earnings calendar and what to watch
VERBIO reports results after market hours on 12 Feb 2026. The company will likely highlight volumes of biodiesel, bioethanol and biomethane, plus margin detail and inventory values. Analysts typically watch gross margin and operating cash flow given recent commodity swings and the company’s negative EPS of -1.87.
A clean beat on margins could prompt a re-rate; a below‑expectation operating cash flow or weak guidance may reverse intraday gains. See the company site for filings and the recent note from MarketBeat for context: VERBIO investor site and MarketBeat coverage.
Q4 drivers and sector context for VBK.DE stock
VERBIO sits in the Basic Materials sector and Chemicals – Specialty industry, where energy and commodity costs matter. Key Q4 drivers are feedstock costs, biomethane prices, and third‑party sales to oil traders and fleets.
Sector momentum in Basic Materials shows mixed returns; VERBIO’s exposure to biofuels ties revenue to commodity cycles. Watch German energy spreads and EU biofuel mandates that can materially affect revenue per litre.
Valuation and fundamentals for VBK.DE stock
VERBIO trades at P/S 0.90, P/B 2.12, and an enterprise value to sales of 1.04. Reported EPS is -1.87 and the trailing P/E is -12.50, reflecting negative earnings. Book value per share is €11.03 and cash per share is €1.07.
Leverage is moderate with debt‑to‑equity 0.40 and current ratio 1.78, but free cash flow per share is negative at -€1.74. These metrics point to valuation support from assets but ongoing earnings and cash‑flow pressure.
Technical picture and intraday trading cues for VBK.DE stock
Intraday range today was €25.18 to €27.30, with price sitting above the 50‑day average of €21.96. Momentum indicators show RSI 62.84 and MACD 1.38 (signal 1.19), indicating bullish momentum but not extreme overbought conditions. ADX 31.34 signals a strong trend.
Volume is elevated at 322,544 versus average 131,355, implying conviction. Traders should monitor breakout above €27.30 for follow‑through or weakness back below €25.18 as a short‑term stop.
Meyka AI rates VBK.DE with a score out of 100 and forecast
Meyka AI rates VBK.DE with a score of 61.49 out of 100 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Meyka AI’s forecast model projects a quarterly price of €34.01 and a 12‑month model price of €12.34. The quarterly figure implies an upside of +33.49% versus the current €25.48. The 12‑month model implies -51.60% downside. Forecasts are model‑based projections and not guarantees.
Earnings scenarios and practical price targets for VBK.DE stock
We outline three scenarios tied to tomorrow’s release. Bull case: margin expansion and strong biomethane sales, target €40.00 (implied +57.00%). Base case: stable margins and modest guidance, target €32.00 (implied +25.59%). Bear case: weak cash flow or unfavorable inventory revaluation, target €15.00 (implied -41.14%).
Use tight risk controls around the release. Given negative EPS and cash flow headwinds, position sizing is critical. For active traders, watch intraday volume spikes and the €27.30 intraday high as a short‑term breakout threshold.
Final Thoughts
VBK.DE stock faces a binary near‑term test as VERBIO reports earnings on 12 Feb 2026. The intraday move to €25.48 on 11 Feb 2026 and volume of 322,544 show the market is positioning ahead of the print. Fundamentals show mixed signals: asset backing with book value €11.03 per share and manageable debt‑to‑equity 0.40, but negative EPS -1.87 and negative free cash flow per share -€1.74. Technically, momentum is constructive with RSI 62.84 and ADX 31.34, and a clean break above €27.30 would validate continued upside.
Meyka AI’s forecast model projects a near‑term quarterly price of €34.01, implying +33.49% upside from €25.48, while a longer 12‑month model sits at €12.34. Those divergent model outcomes underline event risk and model sensitivity to margin and cash‑flow assumptions. Traders should treat tomorrow’s release as a catalyst rather than a confirmation. For longer‑term investors, valuation depends on sustained margin recovery and positive free cash flow. See our live page for updates and intraday moves: VBK.DE stock page on Meyka.
FAQs
When does VERBIO report earnings and how can that move VBK.DE stock?
VERBIO reports after market hours on 12 Feb 2026. Earnings can move VBK.DE stock on margins, biomethane sales, and guidance. A margin beat could lift the price above €27.30; weak cash flow or guidance could trigger sharp selling.
What valuation and risk metrics matter for VBK.DE stock?
Key metrics: P/S 0.90, P/B 2.12, EV/Sales 1.04, EPS -1.87, and debt‑to‑equity 0.40. Major risks are negative free cash flow, commodity volatility, and sensitivity to biofuel mandates.
What does Meyka AI forecast imply for VBK.DE stock?
Meyka AI’s model projects a quarterly price of €34.01 (implied +33.49%) and a 12‑month model price of €12.34 (implied -51.60%). Forecasts are model‑based projections and not guarantees.
What are practical price targets traders can use after earnings?
Practical targets: bull €40.00, base €32.00, bear €15.00. Use intraday stop losses and monitor volume; a move above €27.30 is a bullish confirmation for short‑term traders.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)